TAK-438 - Safety, Blood Levels & Effects of Repeated Doses

Clinical trial NCT02141711 · COMPLETED

Trial details

NCT number: NCT02141711
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Erosive Esophagitis(EE)Gastroesophageal Reflux Disease (GERD)

Start date: 2008-10-01
Primary completion: 2009-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.